Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 13:14:42 - browse：6

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Covid’s new normal has set in amid another rise in cases

WSS

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Why the quest to eradicate polio has stumbled

Why the quest to eradicate polio has stumbled

The struggle to figure out which patients 'deserve' Wegovy

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

WuXi Biologics execs register to lobby as Congress comes for the company

leisure time

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Free medical tuition alone isn't enough to close gaps in primary care

Sports medicine is finally prioritizing gender equality

What happened to the House vote on health price transparency?

Medical records are filled with copy

Abbott's new stent may help patients with peripheral artery disease

State Dept. review finds Biden bears some blame for Afghanistan failures

Cherokee Nation medical school graduates its first class

Drug repurposing or repositioning? The language matters

White House Covid adviser calls on docs to combat misinformation

hotspot

Information blocking fines are now fair game in health care

Ripples from Flovent's discontinuation is killing children with asthma

FDA panel to weigh safety of artificial wombs for preterm births

Why the quest to eradicate polio has stumbled

The White House hikes tariffs on plastic syringes made in China

WuXi Biologics beefs up its lobbying operation

leisure time

focus

leisure time

focus